GalactosemiaGalactose-1-phosphate uridyl transferase deficiency; Galactokinase deficiency; Galactose-6-phosphate epimerase deficiency
Galactosemia is a condition in which the body is unable to use (metabolize) the simple sugar galactose.
Galactosemia is an inherited disorder. This means it is passed down through families. If both parents carry an abnormal gene that can cause galactosemia, each of their children has a 25% chance of being affected.
It occurs in approximately 1 of every 60,000 births among Caucasians. The rate is different for other groups.
There are three forms of the disease:
- Galactose-1 phosphate uridyl transferase deficiency (classic galactosemia, the most common and most severe form)
- Deficiency of galactose kinase
- Deficiency of galactose-6-phosphate epimerase
People with galactosemia are unable to fully break down the simple sugar galactose. Galactose makes up half of lactose, the sugar found in milk. The other sugar is glucose.
If an infant with galactosemia is given milk, substances made from galactose build up in the infant's system. These substances damage the liver, brain, kidneys, and eyes.
Persons with galactosemia cannot tolerate any form of milk (human or animal). They must be careful about eating other foods containing galactose.
Infants with galactosemia can develop symptoms in the first few days of life if they eat formula or breast milk that contains lactose. The symptoms may be due to a serious blood infection with the bacteria E. coli.
- Poor feeding (baby refuses to eat formula containing milk)
- Poor weight gain
- Yellow skin and whites of the eyes (jaundice)
- Amino acids in the urine and/or blood plasma (aminoaciduria)
- Enlarged liver (hepatomegaly)
- Fluid in the abdomen (ascites)
- Low blood sugar (hypoglycemia)
Newborn screening in many states will test for this condition.
- Blood culture for bacteria infection (E. coli sepsis)
- Enzyme activity in the red blood cells
- Ketones in the urine
- Prenatal diagnosis by directly measuring the enzyme galactose-1-phosphate uridyl transferase
- "Reducing substances" in the infant's urine, and normal or low blood sugar while the infant is being fed breast milk or a formula containing lactose
People with this condition must avoid all milk, milk-containing products (including dry milk), and other foods that contain galactose for life. It is essential to read product labels and be an informed consumer.
Infants can be fed with:
- Soy formula
- Meat-based formula or Nutramigen (a protein hydrolysate formula)
- Another lactose-free formula
Calcium supplements are recommended.
Parents of Galactosemic Children, Inc.
People who get an early diagnosis and strictly avoid milk products can live a relatively normal life. However, mild intellectual impairment may develop, even in people who avoid galactose.
- Cirrhosis of the liver
- Death (if there is galactose in the diet)
- Delayed speech development
- Irregular menstrual periods, reduced function of ovaries leading to ovarian failure
- Intellectual disability
- Severe infection with bacteria (E. coli sepsis)
- Tremors and uncontrollable motor functions
When to Contact a Medical Professional
Call your health care provider if:
- Your infant has a combination of galactosemia symptoms
- You have a family history of galactosemia and are considering having children
It is helpful to know your family history. If you have a family history of galactosemia and want to have children, genetic counseling will help you make decisions about pregnancy and prenatal testing. Once the diagnosis of galactosemia is made, genetic counseling is recommended for other members of the family.
Many states screen all newborns for galactosemia. If parents learn that the test indicates possible galactosemia, they should promptly stop giving their infant milk products and ask their health care provider about having blood tests that can be doneto confirm a diagnosis ofgalactosemia.
Berry GT, Walter JH. Disorders of Galactose Metabolism. In: Saudubray JM, van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases: Diagnosis and Treatment. 5th ed. New York, NY: Springer; 2012:chap 7.
Review Date: 5/7/2013
Reviewed By: Chad Haldeman-Englert, MD, FACMG, Wake Forest School of Medicine, Department of Pediatrics, Section on Medical Genetics, Winston-Salem, NC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Bethanne Black, and the A.D.A.M. Editorial team.